Results showed that caffeine significantly reduced the NLRP3 protein level, NLRP3 inflammasome activation, and TLR4/MAPK/NF-κB signaling pathways in a rat model of NASH induced by an atherogenic diet and low CCl4 doses. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatohepatitis.